The nocebo effect as a source of bias in the assessment of treatment effects [version 2; peer review: 1 approved, 2 approved with reservations]

by Karolina Wartolowska
Published 2019-03-01

Blinding in trials of interventional procedures is possible and worthwhile [version 1; referees: 3 approved]

by Karolina Wartolowska, David Beard, Andrew Carr
Published 2017-09-01

Blinding in trials of interventional procedures is possible and worthwhile [version 2; referees: 3 approved]

by Karolina Wartolowska, David Beard, Andrew Carr
Published 2018-01-01

Attitudes and beliefs about placebo surgery among orthopedic shoulder surgeons in the United Kingdom.

by Karolina Wartolowska, David J Beard, Andrew J Carr
Published 2014-01-01

A quantitative, multi-national and multi-stakeholder assessment of barriers to the adoption of cell therapies

by Benjamin M Davies, James Smith, Sarah Rikabi, Karolina Wartolowska, Mark Morrey, Anna French, Robert MacLaren, David Williams, Kim Bure, Rafael Pinedo-Villanueva, Anthony Mathur, Martin Birchall, Evan Snyder, Anthony Atala, Brock Reeve, David Brindley
Published 2017-08-01

Quantitative assessment of barriers to the clinical development and adoption of cellular therapies: A pilot study

by Benjamin M Davies, Sarah Rikabi, Anna French, Rafael Pinedo-Villanueva, Mark E Morrey, Karolina Wartolowska, Andrew Judge, Robert E MacLaren, Anthony Mathur, David J Williams, Ivan Wall, Martin Birchall, Brock Reeve, Anthony Atala, Richard W Barker, Zhanfeng Cui, Dominic Furniss, Kim Bure, Evan Y Snyder, Jeffrey M Karp, Andrew Price, Andrew Carr, David A Brindley
Published 2014-09-01